Free Trial
→ Watch This Robotics Demo Before March 17th (From Brownstone Research) (Ad) Free BTX Stock Alerts

Brooklyn ImmunoTherapeutics (BTX) SEC Filings & 10K Form

Brooklyn ImmunoTherapeutics logo
$7.67 -0.19 (-2.42%)
As of 02/21/2025 03:57 PM Eastern
Compare

Recent Brooklyn ImmunoTherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
8:30 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/17/2024
11:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/05/2024
11:42 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
09/27/2024
3:47 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
09/27/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
3:32 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:14 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:30 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:BTX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored